Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Practice|May 1, 2018
Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulationsAlberto Russu, Jennifer Kern Sliwa, Paulien Ravenstijn, et al.
Advances in Therapy|February 27, 2025
Population Pharmacokinetics of Niraparib/Abiraterone Acetate Administered as Single-Agent Combination and Dual-Acting Tablets Plus Prednisone for Metastatic Castration-Resistant Prostate CancerAlberto Russu, Anasuya Hazra, Hui Tian, et al.
Pharmaceutical Statistics|April 2, 2019
Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learnedFabiola La Gamba, Tom Jacobs, Helena Geys, et al.
Clinical Pharmacokinetics|October 16, 2016
Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with SchizophreniaMats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 20, 2024
Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II)Huybrecht T'jollyn, Raja Venkatasubramanian, Martine Neyens, et al.
CNS Drugs|March 5, 2017
Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial DataMats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.
Clinical Pharmacology and Therapeutics|September 30, 2023
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung CancerNahor Haddish-Berhane, Yaming Su, Alberto Russu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 15, 2024
Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I)Huybrecht T'jollyn, Alberto Russu, Raja Venkatasubramanian, et al.
British Journal of Clinical Pharmacology|June 23, 2016
Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategyMahesh N Samtani, Partha Nandy, Paulien Ravenstijn, et al.
Clinical Pharmacokinetics|March 4, 2024
Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and SimulationAlex Yu, Anasuya Hazra, James Juhui Jiao, et al.
Pageof 3